Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Corcept Therapeutics (NQ: CORT ) 28.59 -0.38 (-1.31%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Corcept Therapeutics < Previous 1 2 3 4 Next > 6 Analysts Have This To Say About Corcept Therapeutics Today 15:00 EDT Via Benzinga Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know June 14, 2024 Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly... Via Benzinga Topics Lawsuit Exposures Financial Legal Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga NASDAQ:CORT is not too expensive for the growth it is showing. May 31, 2024 NASDAQ:CORT is showing good growth, while it is not too expensive. Via Chartmill Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) May 29, 2024 Via Benzinga Exploring the Growth Potential of NASDAQ:CORT as It Nears a Breakout. May 09, 2024 Exploring the Growth Potential of CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as It Nears a Breakout. Via Chartmill 10 Health Care Stocks With Whale Alerts In Today's Session June 03, 2024 Via Benzinga Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday May 28, 2024 Via Benzinga The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts May 02, 2024 Via Benzinga Recap: Corcept Therapeutics Q4 Earnings February 15, 2024 Via Benzinga Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday? May 28, 2024 Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. May 10, 2024 Don't overlook CORCEPT THERAPEUTICS INC (NASDAQ:CORT)—a stock with solid growth prospects and a reasonable valuation. Via Chartmill 10 Health Care Stocks With Whale Alerts In Today's Session May 09, 2024 Via Benzinga CORT Stock Earnings: Corcept Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 CORT stock results show that Corcept Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Earnings Preview: Corcept Therapeutics February 14, 2024 Via Benzinga Despite its growth, NASDAQ:CORT remains within the realm of affordability. January 03, 2024 Looking for growth without the hefty price tag? Consider NASDAQ:CORT. Via Chartmill Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter April 22, 2024 Insights from Corcept Therapeutics' Phase 3 GRACE trial results for endogenous Cushing's syndrome. Discover rapid improvements in hypertension and hyperglycemia without adverse effects. Join us for the... Via Benzinga Exposures Product Safety While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. April 19, 2024 For those who appreciate growth without the sticker shock, CORCEPT THERAPEUTICS INC (NASDAQ:CORT) is worth considering. Via Chartmill Investors seeking growth at a reasonable cost should explore NASDAQ:CORT. March 29, 2024 In the world of growth stocks, CORCEPT THERAPEUTICS INC (NASDAQ:CORT) shines as a value proposition. Via Chartmill Don't overlook NASDAQ:CORT—a stock with solid growth prospects and a reasonable valuation. March 07, 2024 For those who appreciate growth without the sticker shock, CORCEPT THERAPEUTICS INC (NASDAQ:CORT) is worth considering. Via Chartmill What's Going On With Stress Hormone Modulator-Focused Corcept Therapeutics' Stock Friday? February 16, 2024 Findings of Corcept Therapeutics' CATALYST study on Cushing's syndrome & difficult-to-control type 2 diabetes. Via Benzinga While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. February 14, 2024 Investors seeking growth at a reasonable cost should explore NASDAQ:CORT. Via Chartmill While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. January 24, 2024 CORCEPT THERAPEUTICS INC (NASDAQ:CORT), a growth stock which is not overvalued. Via Chartmill Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session January 22, 2024 U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday. Shares of Archer-Daniels-Midland Company (NYSE: ADM) fell sharply in today’s pre-market trading... Via Benzinga Crude Oil Down 2%; Tesla Deliveries Top Estimates January 02, 2024 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded up 0.01% to 37,691.77 while the NASDAQ fell 1.78% to... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session January 02, 2024 Via Benzinga Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 02, 2024 Shares of Longboard Pharmaceuticals, Inc. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.